Medicis Announces First Quarter Fiscal 2004 Conference Call and Webcast.

Business Editors/Health/Medical Writers

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Oct. 27, 2003

Medicis (NYSE:MRX) today announced it expects to report first quarter fiscal 2004 financial results after the market closes on Thursday, October 30, 2003.

Medicis will host a conference call at 5:15 p.m. Eastern Time (2:15 p.m. Pacific Time) to review the September 30, 2003, first quarter financial results, as well as provide an update on other business matters of the Company. A live webcast will be available at http://www.medicis.com. The webcast will be archived on the Company's website for two business days following the live call.

Interested participants should contact Medicis Investor Relations at (602) 808-3854 or investor_relations@medicis.com to reserve a line on the call. Callers should dial in approximately 10 minutes prior to the start of the call. A certain number of lines will be reserved based upon registrations.

The phone number to join the conference call is (719) 457-2657 for both domestic and international callers. No access code is necessary for the live call. For investors unable to participate in the live call, a replay will be available soon after the live call. The phone number to access the replay is (719) 457-0820 and the access code is 172676. The replay will be available for two business days following the live call.

Medicis is the leading independent specialty pharmaceutical company in the United States focusing primarily on the treatment of dermatological, pediatric and podiatric conditions. Medicis has leading prescription products in a number of therapeutic categories, including acne, asthma, eczema, fungal infections, hyperpigmentation, photoaging, psoriasis, rosacea, seborrheic dermatitis and skin and skin-structure infections. The Company's products have earned wide acceptance by both physicians and patients due to their clinical effectiveness, high quality and cosmetic elegance.